Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated short-term hookworm exposure and controlled human challenge
NL-OMON46257Completed
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2018
- Modality
- Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial of Necator americanus larvae and albendazole in hookworm infection (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Average fecal egg count during challenge phase. Started Nov 2018; status: completed.
02
Drugs
Necator americanus larvaealbendazole
03
Conditions
hookworm infection
Beyond the preview
Go deeper on NL-OMON46257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46257.